Cutler Group LP Rigel Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$2.22 - $3.45 $888 - $1,380	-400 Reduced 33.33%	800 $0
Q4 2021 Jan 18, 2022	SELL	$2.36 - $3.57 $13,924 - $21,063	-5,900 Reduced 83.1%	1,200 $0
Q3 2021 Oct 26, 2021	BUY	$3.5 - $4.5 $23,100 - $29,700	6,600 Added 1320.0%	7,100 $0
Q2 2021 Jul 19, 2021	SELL	$3.09 - $4.54 $1,545 - $2,270	-500 Reduced 50.0%	500 $0
Q1 2021 Apr 26, 2021	SELL	$3.35 - $4.93 $15,410 - $22,678	-4,600 Reduced 82.14%	1,000 $0
Q4 2020 Jan 21, 2021	BUY	$2.35 - $3.74 $12,220 - $19,448	5,200 Added 1300.0%	5,600 $0
Q3 2020 Oct 27, 2020	BUY	$1.78 - $4.13 $712 - $1,652	400 New	400 $0
Q2 2019 Aug 09, 2019	SELL	$2.02 - $2.61 $15,150 - $19,575	-7,500 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$2.0 - $2.65 $15,000 - $19,875	7,500 New	7,500 $3,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.